Investors looking to capitalize on Midjourney’s expansion into medical hardware should monitor Butterfly Network (BFLY), which provides the underlying digital ultrasound technology for these next-generation scanners. Arm Holdings (ARM) remains a high-conviction play as it shifts from licensing blueprints to designing high-performance AGI CPUs to meet the insatiable compute demands of AI data centers. The rise of "Biometric Capitalism" suggests long-term growth for companies specializing in self-enhancement and health data, including GLP-1 providers and wearable tech like Oura. In the defense sector, the focus is shifting toward autonomous systems and software-heavy stacks, creating opportunities in Defense Tech and Robotics. For those seeking exposure to late-stage AI giants, growth funds like Antifund are aggressively targeting "big name" private assets including SpaceX, xAI, and OpenAI.

Midjourney Medical (Hardware Expansion)

• Midjourney has announced a new division called Midjourney Medical, expanding from AI image generation into medical hardware. • The primary product is a full-body scanner that utilizes ultrasonic sensors to map internal biological structures. • Technical Specifications: • The device features a ring 70cm in diameter consisting of 358,000 ultrasonic sensors. • It captures data at a rate of 17 gigabytes per second, moving over 40GB of data to visualize a single "slice" of the human body. • The system reconstructs 3D maps across 21 servers with two petaflops of compute power. • It can resolve internal tissue details as small as half a millimeter. • Strategic Vision: • Founder David Holz aims for a fleet of 50,000 scanners capable of performing one billion scans per month. • The goal is to integrate these into "spas" or flagship locations (starting in San Francisco) to make medical imaging feel less clinical and more like a wellness experience (e.g., a sauna or steam room). • Future potential includes "writing" to the body (non-invasive surgeries) using beam-formed light or ultrasonic waves to pulverize tumors.

Takeaways

• Bootstrap Advantage: Midjourney remains a non-venture-backed company. This allows Holz to take "bold bets" and pivot into hardware without the pressure of 18-month VC KPI cycles. • Early Detection Market: The long-term investment thesis is that frequent, high-resolution scanning will catch cancers and diseases significantly earlier than current reactive medical models. • Hardware-Software Synergy: The project leverages Holz’s background in hand-tracking (Leap Motion) and deep learning, suggesting that "AI companies" are increasingly moving into physical "atoms" rather than just "bits."

Butterfly Network (BFLY)

• Midjourney is reportedly partnering with Butterfly Network, a publicly traded digital health company. • Butterfly Network provides the underlying technology/computers for portable ultrasound imaging. • The stock saw a significant price increase (mentioned as up nearly 50% on the day of the news) following the association with Midjourney's medical announcement.

Takeaways

• Public Market Play: For investors unable to access private companies like Midjourney, BFLY represents a liquid way to play the "AI-driven medical imaging" theme. • Validation: The partnership validates Butterfly’s technology stack as a foundational layer for next-generation medical hardware.

Arm Holdings (ARM)

• CEO Rene Haas discussed Arm's transition from an IP-licensing firm to a more direct product company. • New Product Category: Arm recently announced its first AGI CPU, which reportedly offers 2x the performance at the same power levels as competitors. • AI Demand: AI models are "monsters" for compute, memory, and storage. Haas notes that the "law of scaling" (more compute = more capability) has not yet hit a ceiling. • Internal AI Use: Arm uses AI for: • Chip Design: Triage and fixing of bugs in circuit validation. • Financial Forecasting: Predicting royalty revenues with high accuracy. • Legal: Reviewing contracts and standard terms.

Takeaways

• Supply Chain Bottlenecks: Demand for Arm-based CPUs is extremely high, particularly for "agentic" workloads. Arm is actively seeking increased supply capacity. • Strategic Shift: Arm is moving beyond just "blueprints" (IP) into designing more complete systems to capture more value in the AI data center boom.

Antifund (Jake Paul & Geoffrey Woo)

• The venture firm recently closed a $100 million growth fund, which was oversubscribed. • Investment Strategy: • Growth Stage: Investing in "big names" like SpaceX, xAI, and OpenAI. • Venture Stage: Early-stage bets on founders from day one. • Sector Focus: High conviction in Defense Tech, Robotics, Manufacturing, and Bio-AI. • Value Add: The fund provides "marketing support" to highly technical companies (like Etched or Helion) that struggle to reach mainstream users or tell a relatable story.

Takeaways

• The "Testosterone Kardashian" Model: Jake Paul leverages massive distribution (200M+ followers) to provide a "half-solve" for a startup's customer acquisition costs. • Institutional Shift: The fund is moving from personal capital to institutional capital (e.g., Aquarian Holdings), signaling increased sophistication in celebrity-led venture capital.

Investment Themes & Sector Insights

1. The "CEO of the Self" (Biometric Capitalism)

• There is a massive cultural shift toward "self-enhancement" involving GLP-1s, testosterone replacement therapy (TRT), and wearable tech (Oura, Whoop). • Insight: This creates a massive market for "Biometric Capitalism," where individuals manage their health data like a corporate manager.

2. Defense Tech & Re-industrialization

• The nature of warfare is shifting from "4,000 people managing 70 systems" to "70 people managing 40,000 autonomous systems." • Insight: Software is becoming the primary differentiator in defense. Companies like Defense Unicorns are focusing on the "tech stack" for the military, making it easier to deploy modern software on legacy hardware.

3. Biosecurity Risks

• As synthetic biology (SynBio) becomes an "exponential technology" (dropping in cost like computing), the risk of "bio-error" or "bio-terror" increases. • Insight: There is an urgent need for mandatory DNA sequence screening. Companies involved in biosurveillance (e.g., wastewater sequencing in airports) represent a critical, though currently underfunded, infrastructure opportunity.

4. AI "Slop" vs. Taste

• There is a growing business opportunity in "curating" AI output to avoid repetitive, low-quality "slop." • Insight: As AI lowers the barrier to creation, the value shifts to Taste—the ability to discern and produce high-quality, non-generic content. Companies like Taste Labs are raising capital to build "infrastructure for aesthetics."